Biotech Giant Blows Away Expectations After Selling $US3.5 Billion Of Its 'Wonder Drug'

July 24, 2014 12:22 PM

10 0

Biotech Giant Blows Away Expectations After Selling $US3.5 Billion Of Its 'Wonder Drug'

Last night, Gilead Sciences reported earnings and revenue that crushed expectations as sales of its “wonder drug” Sovaldi continued to boom.

Gilead reported adjusted earnings per share of $US2.36, beating expectations for $US1.79, on revenue of $US6.53 billion which topped expectations for $US5.91 billion.

Read more

To category page

Loading...